/
/
/

Zydus Lifesciences Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)1,146.00
Volume (₹)2.07 L
High (₹)1,146.00
Upper Circuit1,257.30
Low (₹)1,125.10
Lower Circuit1,028.70
Prev Close1,143.00
52W High (₹)1,205.00
Price1,133.80
52W Low (₹)835.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)113217.00 Cr
Div. Yield (%)0.09
PE Ratio25.09
Debt to Equity0.43
Price to Book3.23
Book Value269.50
EPS (TTM)45.24
Face Value1.00
ROE (%)19.69

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1905.8-14.2 (-0.74%)
1902
1984.80
4,56,833Cr
9216-23 (-0.25%)
9087
9467
2,45,426Cr
4892-158 (-3.13%)
4885
5066
1,87,320Cr
1133.8-57.2 (-4.80%)
1125.10
1187
1,13,217Cr
1391.6-31.9 (-2.24%)
1376.70
1426.10
1,12,212Cr
1853.9-84.6 (-4.36%)
1811.70
1949
1,01,155Cr
2127-44.5 (-2.05%)
2118.10
2192
97,626Cr
2350.6-32.3 (-1.36%)
2341.20
2419.20
96,859Cr
1164.1-13.9 (-1.18%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr

Key Highlights of Zydus Lifesciences Ltd Balance Sheet

Zydus Lifesciences Ltd balance sheet discloses shareholders' funds of ₹100.6Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹100.6Cr, and the reserves and surplus of the company is ₹23571.1Cr.

The company has its non-current liabilities with total liabilities of ₹39011Cr as of 2026-03-31.

The current liabilities are ₹7883.1Cr as of 2026-03-31. At the same time, current assets are ₹18542.3Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹7273.1Cr and tangible assets of ₹5083.9Cr, provided in the Zydus Lifesciences Ltd financial statements.